Current Report Filing (8-k)
August 30 2021 - 4:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 24, 2021
AdaptHealth Corp.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-38399
|
|
82-3677704
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
220 West Germantown Pike, Suite 250
Plymouth Meeting, PA
|
|
19462
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(610) 630-6357
|
(Registrant’s telephone number, including area code)
|
Not Applicable
|
(Former name or former address, if changed
since last report.)
|
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
Title of each
class
|
|
Trading Symbol(s)
|
|
Name of each
exchange on which registered
|
Common Stock, par value $0.0001 per share
|
|
AHCO
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Director Resignation
On August 24, 2021, Alan Quasha submitted a notice of resignation,
effective as of September 1, 2021, as a member of the Board of Directors of AdaptHealth Corp. (the “Company”). Mr. Quasha
had no disagreement with the Company in connection with his resignation.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
Dated: August 30, 2021
|
AdaptHealth Corp.
|
|
|
|
By:
|
/s/ Jason Clemens
|
|
|
Name: Jason Clemens
|
|
|
Title: Chief Financial Officer
|
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Apr 2023 to Apr 2024